Circularization of Single-Stranded DNA Donor Template Unleashes the Power of Non-Viral Gene Delivery for Long-Term HSCs editing
Letort, G.; Duclert, A.; Le Clerre, D.; Chion-Sotinel, I.; Salvatori, R.; Dessez, E.; Sevin, M.; Rotondi, M.; Ducani, C.; Duchateau, P.; Valton, J.
Show abstract
Over the past decade, non-viral DNA template delivery has been used with engineered nucleases to target single-stranded DNA sequences in hematopoietic stem and progenitor cells. While effective for gene therapy, this method has been limited to short DNA donor templates, restricting its applications to gene corrections. To expand its scope, we developed an editing process using kilobase-long circular single-stranded DNA donor templates and TALEN technology. Our results show that the CssDNA editing process achieves high gene insertion frequency in viable HSPCs. Compared to a conventional AAV-editing process, CssDNA-edited HSPCs show a higher propensity to engraft and maintain gene edits in a murine model. This positive outcome is partly due to higher levels of primitive edited HSPCs, a more quiescent metabolic state, and elevated expression of bone marrow niche adhesion markers. Our findings highlight the strong potential of CssDNA as a universal and efficient non-viral DNA template for gene therapy applications.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency Hemolytic Anemia 98%
- Sort-purification of human CD34+CD90+ cells reduces target cell population and improves lentiviral transduction 96%
- Epigenetic control of multiple genes with a single lentiviral vector encoding transcriptional repressors fused to compact zinc finger arrays 95%
Similar papers in this journal
- TALEN-mediated intron editing of HSPCs enables transgene expression restricted to the myeloid lineage 97%
- Safety and efficacy study of CRISPR/Cas9 treatment of sickle cell disease in clinically relevant conditions highlights disease-specific response 97%
- Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease 96%
Similar papers in this journal
- Adenine base editing is an efficient approach to restore function in FA patient cells without double-stranded DNA breaks 96%
- Functional Profiling of Single CRISPR/Cas9-Edited Human Long-Term Hematopoietic Stem Cells 96%
- Cas9-AAV6 Gene Correction of Beta-Globin in Autologous HSCs Improves Sickle Cell Disease Erythropoiesis in Mice 96%
Similar papers in this journal
- A differentiated and durable allogeneic strategy applicable to cell therapies 97%
- Accessory-cell-free differentiation of hematopoietic stem and progenitor cells into mature red blood cells 91%
- Single-Cell Transcriptomics Reveals Dynamics of NK Cell Expansion in a Feeder Cell-Free Culture of PBMCs - Implications for Immunotherapy 90%
Similar papers in this journal
- Enhanced γ-globin reactivation and sickle cell correction through a repressor-to- activator motif switch in the HBG1/2 promoters 92%
- Single-stranded HDR templates with truncated Cas12a binding sequences improve knock-in efficiencies in primary human T cells 92%
- Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.